← Insider buys
NTLA

Intellia Therapeutics, Inc. · Healthcare

Novartis Institutes For Biomedical Research, Inc. sold $27.9M of Intellia Therapeutics, Inc.

10% owner

Sold$27,870,900
$18.30Price
1,523,000Shares
−27%Stake

What NTLA did after the filing

Prices for NTLA after this filing aren't in yet.

Traded Tue, Dec 12. Filed Thu, Dec 14, 7:19 AM ET, before the open. Not investment advice.